RxFunction, Inc. Company Profile

Background

Founded in 2010 and headquartered in Eden Prairie, Minnesota, RxFunction, Inc. is a medical device company dedicated to designing and marketing technologies that restore balance, increase mobility, and enhance confidence for patients at risk of falling. The company's flagship product, Walkasins®, is a wearable lower limb sensory neuroprosthesis aimed at improving balance and gait in individuals with sensory peripheral neuropathy—a condition characterized by nerve damage in the feet leading to numbness and increased fall risk.

Key Strategic Focus

RxFunction's strategic focus centers on developing non-invasive, wearable medical devices that address balance and mobility impairments due to sensory peripheral neuropathy. By leveraging proprietary technologies, the company aims to provide innovative solutions that enhance patient quality of life. Their primary market includes individuals suffering from peripheral neuropathy, particularly veterans and the elderly, who are at a heightened risk of falls.

Financials and Funding

Since its inception, RxFunction has secured multiple funding rounds to support its research, development, and commercialization efforts. Notably, in November 2023, the company completed a later-stage venture capital round, raising $16.5 million. Additionally, RxFunction has received grants from the National Institutes of Health (NIH) and the U.S. Department of Health and Human Services, underscoring the significance and potential impact of their technology.

Pipeline Development

RxFunction is actively engaged in clinical research to validate and expand the applications of its Walkasins® technology. The "Balance4Mobility" trial (NCT06959277), initiated on June 17, 2025, is a randomized control study assessing the effects of Walkasins® on gait and balance function in individuals with peripheral neuropathy and balance problems. The trial is expected to conclude by June 30, 2027, with results anticipated by June 29, 2028.

Technological Platform and Innovation

At the core of RxFunction's innovation is the Walkasins® device—a non-invasive sensory neuroprosthesis designed to replace lost nerve function by detecting foot pressure and providing immediate tactile sensory cues to aid balance and stability. This technology is protected by multiple patents, including:

Feedback Device with Stimulation of Sensory Nerves for Improved Balance Control: This patent covers a device that measures pressure-related information and provides corresponding stimulation to the wearer, enhancing balance control.

Prosthetic Limb Sensory System for Improved Balance Control: This patent describes a feedback device that measures balance-related information and produces skin stimulation to encode that information, aiding the wearer in balance control.

These proprietary technologies underscore RxFunction's commitment to advancing wearable solutions for balance and mobility impairments.

Leadership Team

RxFunction's leadership comprises experienced professionals dedicated to advancing the company's mission:

Mary Anderson: Chief Executive Officer and Board Member.

Lars Oddsson, Ph.D.: Co-Founder, Co-Inventor, Chief Technology Officer, and Board Member.

Joseph Leach, M.D.: Co-Founder.

Their combined expertise in medical technology and business development positions RxFunction for continued innovation and growth.

Leadership Changes

As of the latest available information, there have been no recent significant changes or appointments within RxFunction's leadership team.

Competitor Profile

Market Insights and Dynamics

The market for medical devices addressing balance and mobility impairments, particularly due to peripheral neuropathy, is substantial and growing. With an estimated 20 million Americans affected by some form of peripheral neuropathy, there is a significant demand for innovative solutions that enhance patient mobility and reduce fall risk.

Competitor Analysis

RxFunction operates in a competitive landscape with several companies developing technologies aimed at improving balance and mobility:

Invicta Medical: A clinical-stage medical technology company developing treatments for sleep apnea.

Vivonics: Provides human health and diagnostics solutions.

SpeechVive: Offers communication solutions for individuals with Parkinson's disease.

Circadian Therapeutics: Develops products targeting diseases associated with circadian rhythm disruption.

While these companies focus on various aspects of medical technology, RxFunction's emphasis on wearable neuroprosthetic devices for balance improvement distinguishes it within the industry.

Strategic Collaborations and Partnerships

RxFunction has engaged in strategic collaborations to enhance its technological capabilities and market reach. Notably, the company received a federal contract from the Defense Health Agency to develop a system incorporating Walkasins® technology into artificial limbs for active-duty military members, veterans, and civilians with lower limb trauma or loss. This project is in collaboration with Liberating Technologies, the research arm of College Park Industries, and is valued at over $1 million.

Operational Insights

RxFunction's strategic considerations include:

Market Position: Focusing on a niche market of individuals with peripheral neuropathy, particularly within the veteran and elderly populations.

Competitive Advantages: Proprietary, non-invasive technology that offers immediate sensory feedback to improve balance and mobility.

Regulatory Compliance: Ensuring adherence to FDA regulations and obtaining necessary approvals for product commercialization.

These factors collectively contribute to RxFunction's distinct position in the medical device industry.

Strategic Opportunities and Future Directions

Looking ahead, RxFunction is poised to:

Expand Clinical Applications: Leverage ongoing clinical trials to validate and broaden the use of Walkasins® for various patient populations.

Enhance Technological Integration: Develop systems that integrate Walkasins® technology into prosthetic limbs, thereby addressing a broader range of mobility impairments.

Strengthen Market Presence: Focus on penetrating healthcare systems, particularly within the Veterans Administration, to reach a larger patient base.

By capitalizing on these opportunities, RxFunction aims to solidify its leadership in the field of wearable medical devices for balance and mobility enhancement.